MedPath

A clinical trial to study the efficacy of local anesthetic drug bupivacaine injected at the site of instrument entry in the abdomen during laparoscopic sterilization in females

Phase 4
Not yet recruiting
Conditions
Administration,
Registration Number
CTRI/2018/10/015982
Lead Sponsor
Dr Aniket Kakade
Brief Summary

this is a randomized, double blind parallel group trial, comparing the efficacy of infiltration and instillation of  local anesthetic drug bupivacaine versus placebo for post operative pain relief after laparoscopic tubal ligation. the drug bupivacaine will be used in dose of 0.25mg/kg of 0.25% solution. 10 ml will be infiltrated at the port site and 20 ml will be instilled intra peritoneal. control group will receive normal saline in same dose. Both group patients will be assessed by a blind assessor every hour by using the visual analogue score [VAS]. rescue analgesia will be administered at VAS 3 when patient complains of pain. any side effects of the drug will also be observed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

all women who present for laparoscopic tubal ligation.

Exclusion Criteria

any intra-operative complication like hematoma formation avulsion of Fallopian tube any allergy to used drug.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome name: Post operative pain relief. Pain to be assessed by visual analogue score [VAS]Time point: One hourly post operative for 6 hours
Secondary Outcome Measures
NameTimeMethod
Outcome Name: Side effects of drugs if anyTime Points: every one hour for 24 hours

Trial Locations

Locations (1)

Bharati Hospital & Research Center

🇮🇳

Pune, MAHARASHTRA, India

Bharati Hospital & Research Center
🇮🇳Pune, MAHARASHTRA, India
Dr Aniket Kakade
Principal investigator
9850988568
aniket1kakade@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.